reference/25082223

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25082223

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	90
issn	0304-3835
pageRange	75-90
publicationName	Cancer Letters
startingPage	75
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fa692fa31ab7b0a951b395b4718a6684 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cf5b9d5995507abc870f68cd20a978d7
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c43cd179932d2e4e1774d0cdd8ecfc4e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_38b65d634421449c21530b5158999961 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_70d7eee219a179c7fd9ba8b30457a180 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_42a59c5cc546d9709b021c393848069e
bibliographicCitation	Bourn JR, Ruiz-Torres SJ, Hunt BG, Benight NM, Waltz SE. Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling. Cancer Letters. 2021 Apr;503():75–90. doi: 10.1016/j.canlet.2021.01.019.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a186dd4b60ff3e0e4edffa515a48f4e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4155-730X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0902-2850 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3572-4642 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8730-1249
date	2021-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/33508385 https://pubmed.ncbi.nlm.nih.gov/PMC7981256 https://doi.org/10.1016/j.canlet.2021.01.019
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2780 https://portal.issn.org/resource/ISSN/0304-3835
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling
discusses	http://id.nlm.nih.gov/mesh/M0215825 http://id.nlm.nih.gov/mesh/M0258081 http://id.nlm.nih.gov/mesh/M0426683 http://id.nlm.nih.gov/mesh/M0328256
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D053592Q000378 http://id.nlm.nih.gov/mesh/D020794Q000378 http://id.nlm.nih.gov/mesh/D007113 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D020794Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015972 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D049109 http://id.nlm.nih.gov/mesh/D061986 http://id.nlm.nih.gov/mesh/D059016 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D015398 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D001943Q000378 http://id.nlm.nih.gov/mesh/D001943Q000235 http://id.nlm.nih.gov/mesh/D009368 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D002470
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_eb2373601a7cb40a7039ccdba92c9d54 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_001107654 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID51135 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4486 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_002438 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_001231866 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19882

Total number of triples: 64.